Search results
Results from the WOW.Com Content Network
The four journals cover developments across the breadth of therapeutic areas and technologies relevant to the drug discovery and development pipeline. However, as of 2022, these titles have been discontinued and incorporated back into Drug Discovery Today. According to the Journal Citation Reports, the journal has a 2022 impact factor of 8.2. [1]
The Trends series was established in 1976 with Trends in Biochemical Sciences, rapidly followed by Trends in Neurosciences, Trends in Pharmacological Sciences, and Immunology Today. Immunology Today, Parasitology Today, and Molecular Medicine Today changed their names to Trends in... in 2001. Drug Discovery Today was spun off as an independent ...
Drug Discovery Today; Drug, Healthcare and Patient Safety; Drug Safety; Drug Metabolism Reviews; Drug Testing and Analysis; European Heart Journal - Cardiovascular Pharmacotherapy; European Journal of Pharmaceutical Sciences; European Journal of Pharmaceutics and Biopharmaceutics; European Journal of Pharmacology; Expert Opinion on Biological ...
It was established in 2002 [1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick. [ 2 ] According to the Journal Citation Reports , the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology" [ 3 ] and 1st out of 279 journals in the ...
npj series. The Nature Partner Journals series, abbreviated npj, is a series of online-only, open access, journals.It was launched in April 2014 with three journals: npj Primary Care Respiratory Medicine, npj Biofilms and Microbiomes, and npj Schizophrenia.
By applying GATC’s MAT AI, drug discovery and development is anticipated to be much faster and more efficient with a greater probability of success. “GATC’s validated technology inverts predicted clinical trial failures and provides an unbiased analysis of investigational new drugs, such as Lisata’s certepetide,” stated Jayson Uffens ...
Image source: The Motley Fool. Pfizer (NYSE: PFE) Q4 2024 Earnings Call Feb 04, 2025, 10:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
Impact factor. 7.050 (2021) ... on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel technologies involved in drug discovery.